Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine gluconate vs fluconazole for recurrent vulvovaginal candidiasis
2020-000758-81Phase 2Completed
- Sponsor
- Karolinska Institutet
- Start
- Oct 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in vulvovaginal candidiasis (VVC) comparing Hibitane arm with Fluconazole arm (2 arms). Primary endpoint: Mycological cure after active treatment. Started Oct 2020; status: completed.
02
Drugs
Hexidinefluconazole
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on 2020-000758-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000758-81.